Streetbeat News

Price Targets

APLS

Needham analyst Joseph Stringer has reaffirmed a Buy rating on Apellis Pharmaceuticals (NASDAQ:APLS) and increased the price target from $70 to $75.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 10:46 am

GTHX

Needham analyst Gil Blum has reiterated a Buy rating on G1 Therapeutics (NASDAQ:GTHX) and maintained a $14 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 10:41 am

AMEH

Stifel analyst Craig Jones has initiated coverage on Apollo Medical Holdings (AMEH) with a Buy rating and set a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 10:36 am

ALHC

Stifel analyst Craig Jones has initiated coverage on Alignment Healthcare (NASDAQ:ALHC) with a Buy rating and set a price target of $11 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 10:32 am

NFLX

Deutsche Bank analyst Bryan Kraft has downgraded Netflix (NASDAQ:NFLX) from Buy to Hold while increasing the price target from $460 to $525. This reflects a more cautious stance on the stock despite a higher valuation expectation.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 10:30 am

RRR

Deutsche Bank analyst Carlo Santarelli has reaffirmed a Buy rating on Red Rock Resorts (NASDAQ:RRR) and increased the price target from $54 to $62, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 10:26 am

NS

Stifel analyst Selman Akyol downgraded NuStar Energy (NYSE:NS) from Buy to Hold while increasing the price target from $20 to $23.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 10:22 am

VZ

Daiwa Capital analyst Jonathan Kees has upgraded Verizon Communications (NYSE:VZ) from Neutral to Outperform and set a price target of $47.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 10:20 am

AMD

New Street Research analyst Pierre Ferragu upgraded Advanced Micro Devices (AMD) from Neutral to Buy and set a price target of $215.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 10:16 am

IBTX

Raymond James analyst Michael Rose has maintained an Outperform rating on Independent Bank Gr (NASDAQ:IBTX) and increased the price target from $56 to $59.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 10:13 am